位置:首页 > 蛋白库 > KAD2_YEAST
KAD2_YEAST
ID   KAD2_YEAST              Reviewed;         222 AA.
AC   P07170; D6VSK8; Q6Q539;
DT   01-APR-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1989, sequence version 2.
DT   03-AUG-2022, entry version 222.
DE   RecName: Full=Adenylate kinase {ECO:0000255|HAMAP-Rule:MF_03168};
DE            EC=2.7.4.3 {ECO:0000255|HAMAP-Rule:MF_03168};
DE   AltName: Full=ATP-AMP transphosphorylase {ECO:0000255|HAMAP-Rule:MF_03168};
DE   AltName: Full=ATP:AMP phosphotransferase {ECO:0000255|HAMAP-Rule:MF_03168};
DE   AltName: Full=Adenylate kinase cytosolic and mitochondrial {ECO:0000255|HAMAP-Rule:MF_03168};
DE   AltName: Full=Adenylate monophosphate kinase {ECO:0000255|HAMAP-Rule:MF_03168};
DE   Flags: Precursor;
GN   Name=ADK1 {ECO:0000255|HAMAP-Rule:MF_03168}; Synonyms=AKY, AKY1, AKY2;
GN   OrderedLocusNames=YDR226W; ORFNames=YD9934.11;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes;
OC   Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2834097; DOI=10.1007/bf00434817;
RA   Magdolen V., Oechsner U., Bandlow W.;
RT   "The complete nucleotide sequence of the gene coding for yeast adenylate
RT   kinase.";
RL   Curr. Genet. 12:405-411(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2821496; DOI=10.1093/nar/15.17.7187;
RA   Proba K., Tomasselli A.G., Nielsen P., Schulz G.E.;
RT   "The cDNA sequence encoding cytosolic adenylate kinase from baker's yeast
RT   (Saccharomyces cerevisiae).";
RL   Nucleic Acids Res. 15:7187-7187(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND FUNCTION.
RX   PubMed=2848829; DOI=10.1016/s0021-9258(19)77657-1;
RA   Konrad M.;
RT   "Analysis and in vivo disruption of the gene coding for adenylate kinase
RT   (ADK1) in the yeast Saccharomyces cerevisiae.";
RL   J. Biol. Chem. 263:19468-19474(1988).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=7885847; DOI=10.1093/nar/23.3.507;
RA   Davies C.J., Hutchison C.A. III;
RT   "Insertion site specificity of the transposon Tn3.";
RL   Nucleic Acids Res. 23:507-514(1995).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169867;
RA   Jacq C., Alt-Moerbe J., Andre B., Arnold W., Bahr A., Ballesta J.P.G.,
RA   Bargues M., Baron L., Becker A., Biteau N., Bloecker H., Blugeon C.,
RA   Boskovic J., Brandt P., Brueckner M., Buitrago M.J., Coster F.,
RA   Delaveau T., del Rey F., Dujon B., Eide L.G., Garcia-Cantalejo J.M.,
RA   Goffeau A., Gomez-Peris A., Granotier C., Hanemann V., Hankeln T.,
RA   Hoheisel J.D., Jaeger W., Jimenez A., Jonniaux J.-L., Kraemer C.,
RA   Kuester H., Laamanen P., Legros Y., Louis E.J., Moeller-Rieker S.,
RA   Monnet A., Moro M., Mueller-Auer S., Nussbaumer B., Paricio N., Paulin L.,
RA   Perea J., Perez-Alonso M., Perez-Ortin J.E., Pohl T.M., Prydz H.,
RA   Purnelle B., Rasmussen S.W., Remacha M.A., Revuelta J.L., Rieger M.,
RA   Salom D., Saluz H.P., Saiz J.E., Saren A.-M., Schaefer M., Scharfe M.,
RA   Schmidt E.R., Schneider C., Scholler P., Schwarz S., Soler-Mira A.,
RA   Urrestarazu L.A., Verhasselt P., Vissers S., Voet M., Volckaert G.,
RA   Wagner G., Wambutt R., Wedler E., Wedler H., Woelfl S., Harris D.E.,
RA   Bowman S., Brown D., Churcher C.M., Connor R., Dedman K., Gentles S.,
RA   Hamlin N., Hunt S., Jones L., McDonald S., Murphy L.D., Niblett D.,
RA   Odell C., Oliver K., Rajandream M.A., Richards C., Shore L., Walsh S.V.,
RA   Barrell B.G., Dietrich F.S., Mulligan J.T., Allen E., Araujo R., Aviles E.,
RA   Berno A., Carpenter J., Chen E., Cherry J.M., Chung E., Duncan M.,
RA   Hunicke-Smith S., Hyman R.W., Komp C., Lashkari D., Lew H., Lin D.,
RA   Mosedale D., Nakahara K., Namath A., Oefner P., Oh C., Petel F.X.,
RA   Roberts D., Schramm S., Schroeder M., Shogren T., Shroff N., Winant A.,
RA   Yelton M.A., Botstein D., Davis R.W., Johnston M., Andrews S., Brinkman R.,
RA   Cooper J., Ding H., Du Z., Favello A., Fulton L., Gattung S., Greco T.,
RA   Hallsworth K., Hawkins J., Hillier L.W., Jier M., Johnson D., Johnston L.,
RA   Kirsten J., Kucaba T., Langston Y., Latreille P., Le T., Mardis E.,
RA   Menezes S., Miller N., Nhan M., Pauley A., Peluso D., Rifkin L., Riles L.,
RA   Taich A., Trevaskis E., Vignati D., Wilcox L., Wohldman P., Vaudin M.,
RA   Wilson R., Waterston R., Albermann K., Hani J., Heumann K., Kleine K.,
RA   Mewes H.-W., Zollner A., Zaccaria P.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome IV.";
RL   Nature 387:75-78(1997).
RN   [6]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=17322287; DOI=10.1101/gr.6037607;
RA   Hu Y., Rolfs A., Bhullar B., Murthy T.V.S., Zhu C., Berger M.F.,
RA   Camargo A.A., Kelley F., McCarron S., Jepson D., Richardson A., Raphael J.,
RA   Moreira D., Taycher E., Zuo D., Mohr S., Kane M.F., Williamson J.,
RA   Simpson A.J.G., Bulyk M.L., Harlow E., Marsischky G., Kolodner R.D.,
RA   LaBaer J.;
RT   "Approaching a complete repository of sequence-verified protein-encoding
RT   clones for Saccharomyces cerevisiae.";
RL   Genome Res. 17:536-543(2007).
RN   [8]
RP   PROTEIN SEQUENCE OF 3-222, AND ACETYLATION AT SER-3.
RX   PubMed=3004985; DOI=10.1111/j.1432-1033.1986.tb09465.x;
RA   Tomasselli A.G., Mast E., Janes W., Schiltz E.;
RT   "The complete amino acid sequence of adenylate kinase from baker's yeast.";
RL   Eur. J. Biochem. 155:111-119(1986).
RN   [9]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, AND DISRUPTION
RP   PHENOTYPE.
RX   PubMed=2850178; DOI=10.1111/j.1432-1033.1988.tb14469.x;
RA   Bandlow W., Strobel G., Zoglowek C., Oechsner U., Magdolen V.;
RT   "Yeast adenylate kinase is active simultaneously in mitochondria and
RT   cytoplasm and is required for non-fermentative growth.";
RL   Eur. J. Biochem. 178:451-457(1988).
RN   [10]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12045196; DOI=10.1074/jbc.m201561200;
RA   Schricker R., Angermayr M., Strobel G., Klinke S., Korber D., Bandlow W.;
RT   "Redundant mitochondrial targeting signals in yeast adenylate kinase.";
RL   J. Biol. Chem. 277:28757-28764(2002).
RN   [11]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N.,
RA   O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [12]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=16823961; DOI=10.1021/pr050477f;
RA   Reinders J., Zahedi R.P., Pfanner N., Meisinger C., Sickmann A.;
RT   "Toward the complete yeast mitochondrial proteome: multidimensional
RT   separation techniques for mitochondrial proteomics.";
RL   J. Proteome Res. 5:1543-1554(2006).
RN   [13]
RP   FUNCTION.
RX   PubMed=18433446; DOI=10.1111/j.1365-2958.2008.06261.x;
RA   Gauthier S., Coulpier F., Jourdren L., Merle M., Beck S., Konrad M.,
RA   Daignan-Fornier B., Pinson B.;
RT   "Co-regulation of yeast purine and phosphate pathways in response to
RT   adenylic nucleotide variations.";
RL   Mol. Microbiol. 68:1583-1594(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22984289; DOI=10.1074/mcp.m112.021105;
RA   Voegtle F.N., Burkhart J.M., Rao S., Gerbeth C., Hinrichs J.,
RA   Martinou J.C., Chacinska A., Sickmann A., Zahedi R.P., Meisinger C.;
RT   "Intermembrane space proteome of yeast mitochondria.";
RL   Mol. Cell. Proteomics 11:1840-1852(2012).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.23 ANGSTROMS) OF 3-221 IN COMPLEX WITH
RP   BI-SUBSTRATE ANALOG AP5A.
RX   PubMed=7635152; DOI=10.1111/j.1432-1033.1995.tb20713.x;
RA   Spuergin P., Abele U., Schulz G.E.;
RT   "Stability, activity and structure of adenylate kinase mutants.";
RL   Eur. J. Biochem. 231:405-413(1995).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (1.63 ANGSTROMS) IN COMPLEX WITH BI-SUBSTRATE ANALOG
RP   AP5A.
RX   PubMed=7670369; DOI=10.1002/pro.5560040702;
RA   Abele U., Schulz G.E.;
RT   "High-resolution structures of adenylate kinase from yeast ligated with
RT   inhibitor Ap5A, showing the pathway of phosphoryl transfer.";
RL   Protein Sci. 4:1262-1271(1995).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.36 ANGSTROMS) OF 3-221 IN COMPLEX WITH ATP ANALOG.
RX   PubMed=8594191; DOI=10.1006/jmbi.1996.0080;
RA   Schlauderer G.J., Proba K., Schulz G.E.;
RT   "Structure of a mutant adenylate kinase ligated with an ATP-analogue
RT   showing domain closure over ATP.";
RL   J. Mol. Biol. 256:223-227(1996).
CC   -!- FUNCTION: Catalyzes the reversible transfer of the terminal phosphate
CC       group between ATP and AMP. Plays an important role in cellular energy
CC       homeostasis and in adenine nucleotide metabolism. Adenylate kinase
CC       activity is critical for regulation of the phosphate utilization and
CC       the AMP de novo biosynthesis pathways. {ECO:0000255|HAMAP-
CC       Rule:MF_03168, ECO:0000269|PubMed:18433446, ECO:0000269|PubMed:2848829,
CC       ECO:0000269|PubMed:2850178}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=AMP + ATP = 2 ADP; Xref=Rhea:RHEA:12973, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:456215, ChEBI:CHEBI:456216; EC=2.7.4.3;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03168,
CC         ECO:0000269|PubMed:2850178};
CC   -!- SUBUNIT: Monomer. {ECO:0000255|HAMAP-Rule:MF_03168,
CC       ECO:0000269|PubMed:7635152, ECO:0000269|PubMed:7670369,
CC       ECO:0000269|PubMed:8594191}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000255|HAMAP-
CC       Rule:MF_03168, ECO:0000269|PubMed:12045196,
CC       ECO:0000269|PubMed:2850178}. Mitochondrion intermembrane space
CC       {ECO:0000255|HAMAP-Rule:MF_03168, ECO:0000269|PubMed:12045196,
CC       ECO:0000269|PubMed:16823961, ECO:0000269|PubMed:22984289,
CC       ECO:0000269|PubMed:2850178}. Note=90% cytoplasmic, 10% mitochondrial.
CC       {ECO:0000269|PubMed:2850178}.
CC   -!- DOMAIN: Consists of three domains, a large central CORE domain and two
CC       small peripheral domains, NMPbind and LID, which undergo movements
CC       during catalysis. The LID domain closes over the site of phosphoryl
CC       transfer upon ATP binding. Assembling and dissambling the active center
CC       during each catalytic cycle provides an effective means to prevent ATP
CC       hydrolysis. {ECO:0000255|HAMAP-Rule:MF_03168,
CC       ECO:0000305|PubMed:24374639, ECO:0000305|PubMed:7635152,
CC       ECO:0000305|PubMed:8594191}.
CC   -!- DISRUPTION PHENOTYPE: The phenotype of disruption mutants is pet,
CC       showing that complementation by another adenylate kinase isozyme occurs
CC       only under fermentative conditions. The disruption completely destroys
CC       the activity in mitochondria, whereas in the cytoplasmic fraction about
CC       10% is retained. {ECO:0000269|PubMed:2850178}.
CC   -!- MISCELLANEOUS: Present with 123000 molecules/cell in log phase SD
CC       medium. {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Belongs to the adenylate kinase family. AK2 subfamily.
CC       {ECO:0000255|HAMAP-Rule:MF_03168}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X06304; CAA29624.1; -; Genomic_DNA.
DR   EMBL; Y00413; CAA68471.1; -; mRNA.
DR   EMBL; M18455; AAA66319.1; -; Genomic_DNA.
DR   EMBL; U13239; AAC33143.1; -; Genomic_DNA.
DR   EMBL; Z48612; CAA88506.1; -; Genomic_DNA.
DR   EMBL; AY558578; AAS56904.1; -; Genomic_DNA.
DR   EMBL; BK006938; DAA12068.1; -; Genomic_DNA.
DR   PIR; S05799; KIBYA.
DR   RefSeq; NP_010512.1; NM_001180534.1.
DR   PDB; 1AKY; X-ray; 1.63 A; A=3-221.
DR   PDB; 1DVR; X-ray; 2.36 A; A/B=3-221.
DR   PDB; 2AKY; X-ray; 1.96 A; A=3-221.
DR   PDB; 3AKY; X-ray; 2.23 A; A=3-221.
DR   PDBsum; 1AKY; -.
DR   PDBsum; 1DVR; -.
DR   PDBsum; 2AKY; -.
DR   PDBsum; 3AKY; -.
DR   AlphaFoldDB; P07170; -.
DR   SMR; P07170; -.
DR   BioGRID; 32278; 96.
DR   DIP; DIP-5129N; -.
DR   IntAct; P07170; 12.
DR   MINT; P07170; -.
DR   STRING; 4932.YDR226W; -.
DR   iPTMnet; P07170; -.
DR   SWISS-2DPAGE; P07170; -.
DR   MaxQB; P07170; -.
DR   PaxDb; P07170; -.
DR   PRIDE; P07170; -.
DR   TopDownProteomics; P07170; -.
DR   EnsemblFungi; YDR226W_mRNA; YDR226W; YDR226W.
DR   GeneID; 851812; -.
DR   KEGG; sce:YDR226W; -.
DR   SGD; S000002634; ADK1.
DR   VEuPathDB; FungiDB:YDR226W; -.
DR   eggNOG; KOG3078; Eukaryota.
DR   GeneTree; ENSGT00940000154576; -.
DR   HOGENOM; CLU_032354_1_0_1; -.
DR   InParanoid; P07170; -.
DR   OMA; FHNRMRV; -.
DR   BioCyc; MetaCyc:YDR226W-MON; -.
DR   BioCyc; YEAST:YDR226W-MON; -.
DR   Reactome; R-SCE-499943; Interconversion of nucleotide di- and triphosphates.
DR   SABIO-RK; P07170; -.
DR   EvolutionaryTrace; P07170; -.
DR   PRO; PR:P07170; -.
DR   Proteomes; UP000002311; Chromosome IV.
DR   RNAct; P07170; protein.
DR   GO; GO:0005737; C:cytoplasm; IDA:SGD.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0005758; C:mitochondrial intermembrane space; IDA:SGD.
DR   GO; GO:0005739; C:mitochondrion; HDA:SGD.
DR   GO; GO:0004017; F:adenylate kinase activity; IDA:SGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0006172; P:ADP biosynthetic process; IDA:SGD.
DR   GO; GO:0046033; P:AMP metabolic process; IEA:UniProtKB-UniRule.
DR   GO; GO:0046034; P:ATP metabolic process; IEA:UniProtKB-UniRule.
DR   GO; GO:0006270; P:DNA replication initiation; IMP:SGD.
DR   GO; GO:0009117; P:nucleotide metabolic process; IMP:SGD.
DR   GO; GO:0016310; P:phosphorylation; IEA:UniProtKB-KW.
DR   CDD; cd01428; ADK; 1.
DR   Gene3D; 3.40.50.300; -; 1.
DR   HAMAP; MF_00235; Adenylate_kinase_Adk; 1.
DR   HAMAP; MF_03168; Adenylate_kinase_AK2; 1.
DR   InterPro; IPR006259; Adenyl_kin_sub.
DR   InterPro; IPR000850; Adenylat/UMP-CMP_kin.
DR   InterPro; IPR033690; Adenylat_kinase_CS.
DR   InterPro; IPR007862; Adenylate_kinase_lid-dom.
DR   InterPro; IPR028587; AK2.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR23359; PTHR23359; 1.
DR   Pfam; PF05191; ADK_lid; 1.
DR   PRINTS; PR00094; ADENYLTKNASE.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   TIGRFAMs; TIGR01351; adk; 1.
DR   PROSITE; PS00113; ADENYLATE_KINASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Cytoplasm;
KW   Direct protein sequencing; Kinase; Mitochondrion; Nucleotide-binding;
KW   Reference proteome; Transferase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   PROPEP          2
FT                   /note="Removed in mature form"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03168,
FT                   ECO:0000269|PubMed:3004985"
FT                   /id="PRO_0000016550"
FT   CHAIN           3..222
FT                   /note="Adenylate kinase"
FT                   /id="PRO_0000016551"
FT   REGION          36..65
FT                   /note="NMP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03168,
FT                   ECO:0000269|PubMed:7635152, ECO:0000269|PubMed:7670369"
FT   REGION          133..170
FT                   /note="LID"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03168,
FT                   ECO:0000269|PubMed:7635152, ECO:0000269|PubMed:7670369"
FT   BINDING         16..21
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03168,
FT                   ECO:0000269|PubMed:7635152, ECO:0000269|PubMed:7670369,
FT                   ECO:0000269|PubMed:8594191"
FT   BINDING         37
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03168,
FT                   ECO:0000269|PubMed:7635152, ECO:0000269|PubMed:7670369"
FT   BINDING         42
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03168,
FT                   ECO:0000269|PubMed:7635152, ECO:0000269|PubMed:7670369"
FT   BINDING         63..65
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03168,
FT                   ECO:0000269|PubMed:7635152, ECO:0000269|PubMed:7670369"
FT   BINDING         92..95
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03168,
FT                   ECO:0000269|PubMed:7635152, ECO:0000269|PubMed:7670369"
FT   BINDING         99
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03168,
FT                   ECO:0000269|PubMed:7635152, ECO:0000269|PubMed:7670369"
FT   BINDING         134
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03168,
FT                   ECO:0000269|PubMed:7635152, ECO:0000269|PubMed:7670369,
FT                   ECO:0000269|PubMed:8594191"
FT   BINDING         143..144
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:7635152,
FT                   ECO:0000269|PubMed:7670369, ECO:0000269|PubMed:8594191"
FT   BINDING         167
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03168,
FT                   ECO:0000269|PubMed:7635152, ECO:0000269|PubMed:7670369"
FT   BINDING         178
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03168,
FT                   ECO:0000269|PubMed:7635152, ECO:0000269|PubMed:7670369"
FT   BINDING         206
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03168,
FT                   ECO:0000269|PubMed:7635152, ECO:0000269|PubMed:7670369,
FT                   ECO:0000269|PubMed:8594191"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   MOD_RES         3
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03168,
FT                   ECO:0000269|PubMed:3004985"
FT   CONFLICT        95
FT                   /note="R -> K (in Ref. 7; AAS56904)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        139
FT                   /note="A -> R (in Ref. 2; CAA68471)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        222
FT                   /note="D -> N (in Ref. 8; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   STRAND          8..12
FT                   /evidence="ECO:0007829|PDB:1AKY"
FT   HELIX           19..30
FT                   /evidence="ECO:0007829|PDB:1AKY"
FT   STRAND          33..36
FT                   /evidence="ECO:0007829|PDB:1AKY"
FT   HELIX           37..46
FT                   /evidence="ECO:0007829|PDB:1AKY"
FT   HELIX           50..60
FT                   /evidence="ECO:0007829|PDB:1AKY"
FT   HELIX           67..80
FT                   /evidence="ECO:0007829|PDB:1AKY"
FT   HELIX           82..85
FT                   /evidence="ECO:0007829|PDB:1AKY"
FT   STRAND          88..92
FT                   /evidence="ECO:0007829|PDB:1AKY"
FT   HELIX           97..110
FT                   /evidence="ECO:0007829|PDB:1AKY"
FT   STRAND          116..121
FT                   /evidence="ECO:0007829|PDB:1AKY"
FT   HELIX           124..132
FT                   /evidence="ECO:0007829|PDB:1AKY"
FT   STRAND          134..136
FT                   /evidence="ECO:0007829|PDB:1AKY"
FT   TURN            138..140
FT                   /evidence="ECO:0007829|PDB:1AKY"
FT   STRAND          143..145
FT                   /evidence="ECO:0007829|PDB:1AKY"
FT   TURN            146..148
FT                   /evidence="ECO:0007829|PDB:1AKY"
FT   TURN            158..160
FT                   /evidence="ECO:0007829|PDB:1AKY"
FT   HELIX           172..185
FT                   /evidence="ECO:0007829|PDB:1AKY"
FT   HELIX           188..195
FT                   /evidence="ECO:0007829|PDB:1AKY"
FT   STRAND          199..203
FT                   /evidence="ECO:0007829|PDB:1AKY"
FT   HELIX           208..219
FT                   /evidence="ECO:0007829|PDB:1AKY"
SQ   SEQUENCE   222 AA;  24255 MW;  FE566FD8015907CE CRC64;
     MSSSESIRMV LIGPPGAGKG TQAPNLQERF HAAHLATGDM LRSQIAKGTQ LGLEAKKIMD
     QGGLVSDDIM VNMIKDELTN NPACKNGFIL DGFPRTIPQA EKLDQMLKEQ GTPLEKAIEL
     KVDDELLVAR ITGRLIHPAS GRSYHKIFNP PKEDMKDDVT GEALVQRSDD NADALKKRLA
     AYHAQTEPIV DFYKKTGIWA GVDASQPPAT VWADILNKLG KD
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025